Exencial Wealth Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Buy
58,863
+5,560
+10% +$175K 0.06% 232
2025
Q4
$1.57M Buy
53,303
+2,580
+5% +$71.7K 0.05% 248
2025
Q3
$1.28M Buy
50,723
+2,804
+6% +$68.3K 0.04% 255
2025
Q2
$1.15M Buy
47,919
+2,934
+7% +$68K 0.04% 271
2025
Q1
$1.03M Buy
44,985
+1,453
+3% +$35.1K 0.04% 276
2024
Q4
$1.1M Buy
43,532
+972
+2% +$24.6K 0.04% 272
2024
Q3
$1.06M Buy
42,560
+2,204
+5% +$65.3K 0.04% 269
2024
Q2
$1.2M Sell
40,356
-806
-2% -$22.4K 0.04% 253
2024
Q1
$1.24M Buy
41,162
+13,680
+50% +$380K 0.05% 248
2023
Q4
$786K Buy
+27,482
New +$807K 0.03% 288

Other funds holding RTO

Exencial Wealth Advisors's RTO Position: Q1 2026 in Review

Exencial Wealth Advisors increased its Rentokil (RTO) stake by 10% in Q1 2026, buying an estimated $175K and bringing the position to 58,863 shares worth $1.85M. The position accounts for 0.06% of the portfolio, ranked #232.

Exencial Wealth Advisors first reported a position in RTO in Q4 2023 and has held it in 10 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Exencial Wealth Advisors held 58,863 shares of Rentokil worth $1.85M as of Q1 2026.
  • Exencial Wealth Advisors bought 5,560 Rentokil shares in Q1 2026, an estimated $175K.
  • Rentokil made up 0.06% of Exencial Wealth Advisors's portfolio in Q1 2026, its #232 holding.
  • Exencial Wealth Advisors first reported a position in Rentokil in Q4 2023 and has held it in 10 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.